Hundreds of People Mistakenly Told They Have Cancer in Biotech Software Mishap The biotechnology company, Grail, said a software issue caused one of its vendors to accidentally send nearly 400 letters mistakenly telling patients they have cancer.

By Madeline Garfinkle

Opinions expressed by BIZ Experiences contributors are their own.

Grail
Galleri is a multi-cancer detection kit that scans for signals of more than 50 kinds of cancer.

Biotech company Grail announced on Friday that hundreds of patients were mistakenly informed they may have cancer after purchasing one of its products, Galleri.

According to the company, Galleri scans for and detects "common cancer signals" of more than 50 types of cancer through a simple blood draw, the results of which then inform further diagnosis. It's only available through a prescription from a healthcare provider and while cost may vary depending on coverage, the Galleri test kit has a listing price of $949.

Grail attributed the mishap to one of its vendors, PWNHealth, saying it was the result of "software configuration issues," which have since been resolved, the company told BIZ Experiences. On May 19, Grail was notified by PWNHealth that inaccurate form letters were sent to about 400 individuals between May 10 and May 18.

Related: The Career Rise and Fall of Theranos Founder Elizabeth Holmes

Upon notification of the software incident by PWNHealth, Grail reached out to the 400 patients who had received incorrect letters by telephone or email until Grail could confirm that every affected individual was informed of the mistake.

The company also said the letters with incorrect results were "in no way related to or caused by an incorrect Galleri test result" and more than half of the individuals who received false test results hadn't even had their blood drawn yet for the Galleri test.

Since using Galleri requires a formal blood draw, Grail works with a series of independent telemedicine vendors, like PWNHealth, to administer and review blood tests for Galleri and then subsequently deliver results to the individuals.

BIZ Experiences has reached out to PWNHealth for comment.

Related: The 9 Biggest Bookkeeping Mistakes Small Businesses Make (and How to Avoid Them)

Madeline Garfinkle

News Writer

Madeline Garfinkle is a News Writer at BIZ Experiences.com. She is a graduate from Syracuse University, and received an MFA from Columbia University. 

Want to be an BIZ Experiences Leadership Network contributor? Apply now to join.

Business Ideas

70 Small Business Ideas to Start in 2025

We put together a list of the best, most profitable small business ideas for BIZ Experiencess to pursue in 2025.

Science & Technology

OpenAI's Latest Move Is a Game Changer — Here's How Smart Solopreneurs Are Turning It Into Profit

OpenAI's latest AI tool acts like a full-time assistant, helping solopreneurs save time, find leads and grow their business without hiring.

Social Media

How To Start a Youtube Channel: Step-by-Step Guide

YouTube can be a valuable way to grow your audience. If you're ready to create content, read more about starting a business YouTube Channel.

Money & Finance

These Are the Expected Retirement Ages By Generation, From Gen Z to Boomers — and the Average Savings Anticipated. How Do Yours Compare?

Many Americans say inflation prevents them from saving enough and fear they won't reach their financial goals.

Starting a Business

I Built a $20 Million Company by Age 22 While Still in College. Here's How I Did It and What I Learned Along the Way.

Wealth-building in your early twenties isn't about playing it safe; it's about exploiting the one time in life when having nothing to lose gives you everything to gain.

Science & Technology

AI Isn't Plug-and-Play — You Need a Strategy. Here's Your Guide to Building One.

Don't just "add AI" — build a strategy. This guide helps founders avoid common pitfalls and create a step-by-step roadmap to harness real value from AI.